Where ShockWave Medical Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for ShockWave Medical (NASDAQ:SWAV) in the last quarter, with an average 12-month price target of $279.73. The average price target has increased by 9.11% over the past month.

May 30, 2023 | 8:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ShockWave Medical has an average 12-month price target of $279.73, with a 9.11% increase over the past month.
The average 12-month price target for ShockWave Medical has increased by 9.11% over the past month, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors react to the updated price targets.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100